Tactile Medical Sees FY24 Revenue $293M-$298M Vs $302.950M Est.
Portfolio Pulse from Benzinga Newsdesk
Tactile Medical has revised its FY24 revenue guidance to $293M-$298M, which is below the previous estimate of $302.950M.
August 05, 2024 | 8:58 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Tactile Medical has lowered its FY24 revenue guidance to $293M-$298M, which is below the previous estimate of $302.950M. This revision may negatively impact investor sentiment and the stock price in the short term.
The downward revision in revenue guidance indicates potential challenges in achieving previously expected growth, which could lead to negative investor sentiment and a decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100